TRDA
Entrada Therapeutics, Inc. · Healthcare
Baker Bros. Advisors LP bought $261K of Entrada Therapeutics, Inc.
10% owner
Bought$260,760
$6.37Price
40,947Shares
+1%Stake
What TRDA did for a copier
- $1,000 copied at Tue, Jun 7 open, $6.71
- $1,562
- S&P 500, same days
- −1.9%
Measured over 30 trading days, to the Jul 21 close.
Baker Bros. Advisors LP's record
21 other buys with 3 months of prices since 2016: on average +8.9% against the S&P 500, and 11 of 21 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Jun 2. Filed Mon, Jun 6, 5:07 PM ET, after the close. Returns use the Jun 7 open and the Jul 21 close. Not investment advice.